Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BVMF/PNVL3 stock hub

BVMF/PNVL3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/PNVL3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/PNVL3

In the news

Latest news · BVMF/PNVL3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.2

P25 n/aP50 n/aP75 n/a

Trailing P/E15.3

P25 n/aP50 n/aP75 n/a

ROE10.4

P25 n/aP50 n/aP75 n/a

ROIC9.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/PNVL3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

249

Groups with data

Currency

BRL

Showing 249 of 249 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Brazil
Country code	BR
Employees	11,282
Employees Change	1,137%
Employees Change Percent	11.21
Enterprise value	BRL 3.1B
Exchange	Brazil Stock Exchange
Financial currency	BRL
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	BRPNVLACNOR9
Last refreshed	2026-05-10
Market cap	BRL 2B
Price	BRL 13.59
Price currency	BRL
Rev Per Employee	505,503.55x
Sector	Healthcare
Sic	2834
Symbol	bvmf/PNVL3
Website	https://www.grupopanvel.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.55%
EV Earnings	23.44x
EV/EBIT	11.42x
EV/EBITDA	6.9x
EV/FCF	9.33x
EV/Sales	0.54x
FCF yield	16.46%
Forward P/E	11.23x
P/B ratio	1.55x
P/E ratio	15.26x
P/S ratio	0.35x
PE Ratio10 Y	28.66x
PE Ratio3 Y	16.1x
PE Ratio5 Y	20.76x
PEG ratio	0.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.76%
EBITDA Margin	6.01%
FCF margin	5.83%
Gross margin	33.14%
Gross Profit	BRL 1.9B
Gross Profit Growth	13.91%
Gross Profit Growth Q	18.45%
Gross Profit Growth3 Y	13.66%
Gross Profit Growth5 Y	17.08%
Net Income	BRL 132.4M
Net Income Growth	18.1%
Net Income Growth Q	38.02%
Net Income Growth Quarters	1%
Net Income Growth Years	5%
Net Income Growth3 Y	13.01%
Net Income Growth5 Y	17.28%
Pretax Margin	2.69%
Profit Margin	2.32%
Profit Per Employee	BRL 11,733
Profitable Years	22
ROA	4.97
Roa5y	3.59
ROCE	10.96
ROE	10.4
Roe5y	8.51
ROIC	9.49
Roic5y	8.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.19%
Cagr15y	12.33%
Cagr1y	55.15%
Cagr20y	17.45%
Cagr3y	12.28%
Cagr5y	-4.44%
Div CAGR10	12.29%
Div CAGR3	16.98%
Div CAGR5	20.92%
EPS Growth	18.57
EPS Growth Q	39.34
EPS Growth Quarters	1
EPS Growth Years	5
EPS Growth3 Y	12.69
EPS Growth5 Y	17.5
FCF Growth	245%
FCF Growth Q	179.05%
FCF Growth3 Y	84.17%
FCF Growth5 Y	39.22%
OCF Growth	110.78%
OCF Growth Q	64.96%
OCF Growth10 Y	20.62%
OCF Growth3 Y	32.05%
OCF Growth5 Y	29.28%
Revenue Growth	11.53x
Revenue Growth Q	16.26x
Revenue Growth Quarters	22x
Revenue Growth Years	21x
Revenue Growth3 Y	11.37x
Revenue Growth5 Y	14.35x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 1.67
Assets	BRL 3.7B
Cash	BRL 304M
Current Assets	BRL 2.3B
Current Liabilities	BRL 1.3B
Debt	BRL 1.4B
Debt EBITDA	BRL 3.08
Debt Equity	BRL 1.07
Debt FCF	BRL 4.17
Equity	BRL 1.3B
Interest Coverage	1.97
Liabilities	BRL 2.4B
Long Term Assets	BRL 1.4B
Long Term Liabilities	BRL 1B
Net Cash	BRL -1.1B
Net Cash By Market Cap	BRL -53.53
Net Debt EBITDA	BRL 3.16
Net Debt Equity	BRL 0.83
Net Debt FCF	BRL 3.25
Tangible Book Value	BRL 1.2B
Tangible Book Value Per Share	BRL 8.02
WACC	7.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.81
Inventory Turnover	3.56
Net Working Capital	BRL 925.5M
Quick ratio	0.81
Working Capital	BRL 961.1M
Working Capital Turnover	BRL 6.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.08%
Dividend Growth	3.33%
Dividend Growth Years	0%
Dividend per share	BRL 0.34
Dividend Years	35
Dividend Yield	2.52%
Ex Div Date	2026-03-27
Last Dividend	BRL 0.09
Payout Frequency	Quarterly
Payout Ratio	21.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	50.73%
1Y total return	55.1%
200-day SMA	11.67
3Y total return	41.58%
50-day SMA	14.54
50-day SMA vs 200-day SMA	50over200
5Y total return	-20.29%
All Time High	34.46
All Time High Change	-60.56%
All Time High Date	2020-07-13
All Time Low	0
All Time Low Change	301,900%
All Time Low Date	1993-03-29
ATR	0.52
Beta	0.43
Beta1y	0.38
Beta2y	0.33
Ch YTD	13.34
High	13.69
High52	16.57
High52 Date	2026-02-26
High52ch	-17.98%
Low	13.41
Low52	8.06
Low52 Date	2025-06-09
Low52ch	68.61%
Ma50ch	-6.55%
Price vs 200-day SMA	16.42%
RSI	42.78
RSI Monthly	58.82
RSI Weekly	54.76
Sharpe ratio	1.42x
Sortino ratio	2.52
Total Return	2.6%
Tr YTD	15.38
Tr15y	471.68%
Tr1m	-3.41%
Tr1w	-1.66%
Tr3m	-5.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 271.7M
Operating Income Growth	30.15
Operating Income Growth Q	33.42
Operating Income Growth3 Y	23.05
Operating Income Growth5 Y	22.42
Operating margin	4.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	65,924,265%
Net Borrowing	-41,878,000
Shares Insiders	49.37%
Shares Institutions	13.31%
Shares Out	148,684,615
Shares Qo Q	-0.38%
Shares Yo Y	-0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 325.5M
Average Volume	736,495x
Bv Per Share	8.75
CAPEX	BRL -118.2M
Ch10y	27.45
Ch15y	347.5
Ch1m	-3.41
Ch1w	-1.66
Ch1y	50.67
Ch20y	1,598.8
Ch3m	-6.47
Ch3y	29.43
Ch5y	-29.44
Ch6m	43.05
Change	1.57%
Change From Open	-0.73
Close	13.38
Days Gap	2.32
Depreciation Amortization	65,691,000
Dollar Volume	6,406,326
Earnings Date	2026-05-14
EBIT	BRL 271.7M
EBITDA	BRL 342.6M
EPS	BRL 0.89
F Score	7
FCF	BRL 332.6M
FCF EV Yield	10.72x
FCF Per Share	BRL 2.24
Financing CF	-235,001,000
Fiscal Year End	December
Founded	1,920
Goodwill	5,069,000
Graham Number	13.2354
Graham Upside	-2.61
Income Tax	BRL 21.1M
Investing CF	-286,716,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Last Split Date	2020-03-23
Last Split Type	Forward
Lynch Fair Value	BRL 15.39
Lynch Upside	13.22
Ma150	12.32
Ma150ch	10.29%
Ma20	14.13
Ma20ch	-3.82%
Net CF	-70,949,000
Next Earnings Date	2026-05-14
Open	13.69
P FCF Ratio	6.08
P OCF Ratio	4.48
Payment Date	2027-05-31
Position In Range	64.29
Ppne	1,335,365,000
Price Date	2026-05-08
Price EBITDA	BRL 5.9
Ptbv Ratio	1.69
Relative Volume	0.65x
Revenue	5,703,091,000x
SBC By Revenue	0.12x
Share Based Comp	7,061,000
Tax By Revenue	0.37x
Tax Rate	13.73%
Tr20y	2,394.49%
Tr6m	45.62%
Volume	471,400

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/PNVL3 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.5%

$0.34 annual per share

Payout ratio

+21.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+20.9%

0 consecutive years of growth

Total shareholder yield

+2.6%

Next ex-dividend date: 2026-03-27

Performance

BVMF/PNVL3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/PNVL3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.3%

Share of float held by funds and institutions

Insider ownership

+49.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

BVMF/PNVL3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.8

Neutral momentum band

Price vs 200-day MA

+16.4%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

1.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/PNVL3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/PNVL3 stock rating?

bvmf/PNVL3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/PNVL3 analysis?

The full report lives at /stocks/bvmf/PNVL3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/PNVL3?

The latest report frames bvmf/PNVL3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/PNVL3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.